MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $30.1M of Moderna, Inc.
Sold$30,087,339
$148.34Price
202,832Shares
−2%Stake
What MRNA did after the filing
- The stock from Wed, Jun 12 open, $150.00
- −18.6%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Jul 26 close.
Traded Tue, Jun 11. Filed Tue, Jun 11, 7:01 PM ET, after the close. Returns use the Jun 12 open and the Jul 26 close. Not investment advice.